| Product Code: ETC9556714 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Sweden Hereditary Angioedema Market Overview |
3.1 Sweden Country Macro Economic Indicators |
3.2 Sweden Hereditary Angioedema Market Revenues & Volume, 2021 & 2031F |
3.3 Sweden Hereditary Angioedema Market - Industry Life Cycle |
3.4 Sweden Hereditary Angioedema Market - Porter's Five Forces |
3.5 Sweden Hereditary Angioedema Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Sweden Hereditary Angioedema Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 Sweden Hereditary Angioedema Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Sweden Hereditary Angioedema Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Growing awareness about hereditary angioedema (HAE) among healthcare professionals and patients |
4.2.2 Increasing research and development activities for innovative HAE treatments |
4.2.3 Favorable government initiatives and policies supporting access to HAE therapies |
4.3 Market Restraints |
4.3.1 High cost associated with HAE treatments and therapies |
4.3.2 Limited availability of specialized healthcare facilities for HAE diagnosis and management |
4.3.3 Challenges in accurate diagnosis and differentiation of HAE from other similar conditions |
5 Sweden Hereditary Angioedema Market Trends |
6 Sweden Hereditary Angioedema Market, By Types |
6.1 Sweden Hereditary Angioedema Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Sweden Hereditary Angioedema Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 Sweden Hereditary Angioedema Market Revenues & Volume, By C1 Esterase Inhibitor, 2021- 2031F |
6.1.4 Sweden Hereditary Angioedema Market Revenues & Volume, By Selective Bradykinin B2 Receptor Antagonist, 2021- 2031F |
6.1.5 Sweden Hereditary Angioedema Market Revenues & Volume, By Kallikrein Inhibitor, 2021- 2031F |
6.1.6 Sweden Hereditary Angioedema Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Sweden Hereditary Angioedema Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 Sweden Hereditary Angioedema Market Revenues & Volume, By Intravenous, 2021- 2031F |
6.2.3 Sweden Hereditary Angioedema Market Revenues & Volume, By Subcutaneous Injection, 2021- 2031F |
6.2.4 Sweden Hereditary Angioedema Market Revenues & Volume, By Oral, 2021- 2031F |
6.3 Sweden Hereditary Angioedema Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Sweden Hereditary Angioedema Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.3.3 Sweden Hereditary Angioedema Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.3.4 Sweden Hereditary Angioedema Market Revenues & Volume, By Others, 2021- 2031F |
7 Sweden Hereditary Angioedema Market Import-Export Trade Statistics |
7.1 Sweden Hereditary Angioedema Market Export to Major Countries |
7.2 Sweden Hereditary Angioedema Market Imports from Major Countries |
8 Sweden Hereditary Angioedema Market Key Performance Indicators |
8.1 Number of diagnosed HAE cases annually |
8.2 Patient adherence to HAE treatment regimens |
8.3 Rate of adoption of new HAE therapies in the market |
9 Sweden Hereditary Angioedema Market - Opportunity Assessment |
9.1 Sweden Hereditary Angioedema Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Sweden Hereditary Angioedema Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 Sweden Hereditary Angioedema Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Sweden Hereditary Angioedema Market - Competitive Landscape |
10.1 Sweden Hereditary Angioedema Market Revenue Share, By Companies, 2024 |
10.2 Sweden Hereditary Angioedema Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here